Comparing airway management techniques for single-lung ventilation in heart surgery
Comparison of Postoperative Pulmonary Complications in Patients Undergoing Minimal Invasive Cardiac Surgeries With the Use of Bronchial Blocker and Double-Lumen Tube in Airway Management
This study is testing whether using a double-lumen tube or a bronchial blocker is better for helping patients breathe during heart surgery that only requires one lung to be used.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 66 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara, Çankaya) |
| Trial ID | NCT06299735 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare the effectiveness of a double-lumen tube versus a bronchial blocker for single-lung ventilation in patients undergoing minimally invasive cardiac surgeries. It is a single-center, prospective, randomized study involving 66 patients who will be randomly assigned to one of the two airway management techniques. The study will evaluate postoperative pulmonary functions, duration of application, success in lung collapse, and the number of repositioning attempts for both methods. Standard anesthesia protocols will be followed for all participants.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and above scheduled for on-pump minimally invasive cardiac surgeries requiring single-lung ventilation.
Not a fit: Patients with advanced organ failure, severe lung diseases, or those undergoing emergency surgeries may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve postoperative pulmonary outcomes for patients undergoing minimally invasive cardiac surgery.
How similar studies have performed: Previous studies have shown varying success with similar airway management techniques, but this specific comparison is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients planned for on-pump minimal invasive cardiac surgical procedures requiring single-lung ventilation * Female and male patients aged 18 and above * Patients with ASA scores of 1-2-3 * Patients with signed informed consent to participate in the study * Patients with a Body Mass Index (BMI) less than 40 Exclusion Criteria: * Emergency surgeries * Patients with ASA scores greater than 3 * Advanced-stage organ (heart, kidney, liver, lung) failure * Advanced lung diseases (COPD, FEV1\<50%, restrictive lung diseases, history of chest surgery, Pulmonary Hypertension, PAB\>30mmHg) * Patients with anticipated difficult intubation * Pregnant individuals * Patients with a BMI greater than 40 * Patients lacking the ability to read, understand, sign the informed consent form, and those who do not wish to participate in the study
Where this trial is running
Ankara, Çankaya
- Ankara bilkent city hospital — Ankara, Çankaya, Turkey (Recruiting)
Study contacts
- Principal investigator: Nevriye Salman — ankara bilkent city hospital, anesthesiology and reanimation clinic
- Study coordinator: Asena Irem Yildiz
- Email: asenairemyildiz@gmail.com
- Phone: +905348129624
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.